| Reviews |
 |
|
|
|
|
Reviews to:
Date: Saturday, 28. November 2015
Author: Gast
Review:
Who would I report to? oxytrol for men InterMune, which is in the process of being acquired by Roche for $8.3 billion, says that data over 72 weeks provides further evidence of a durable pirfenidone treatment benefit on multiple measures of idiopathic pulmonary fibrosis including reducing the risk of mortality.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
